RTI Biologics, Inc. (NASDAQ:RTIX)
| CAPS Rating |
|
|---|---|
| Open | $3.98 |
| Previous Close | $4.02 |
| Daily Range | $3.93 - $4.06 |
| 52-Week Range | $2.50 - $4.79 |
| Market Cap | $221.18M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 200,812 |
| Average Daily Volume | 0 |
How do you think RTIX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
RTIX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
RTIX News and Commentary
- RTI Biologics Outruns Estimates Again – The Motley Fool
- 5-Star Stocks Poised to Pop: RTI Biologics – The Motley Fool
- Why RTI Biologics May Be About to Take Off – The Motley Fool
- RTI Biologics is a new growth Biomed – Blog at The Motley Fool
- RTI Biologics buy signals – Blog at The Motley Fool
- RTI Biologics Passes This Key Test – The Motley Fool
- Stem-Cell Stocks May Now Be Worth The Risk – SmartMoney
- Is a Revenue Miss Coming for Synovis Life Technologies? – The Motley Fool
- RTI Biologics Passes This Key Test – The Motley Fool
- 5 Stocks Insiders Are Certain Will Outperform the Market – SeekingAlpha
- RTI Biologics CEO Discusses Q3 2010 Results - Earnings Call Transcript – SeekingAlpha
- RTI Biologics CEO Discusses Q3 2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Value Opportunities Created by Mutual Fund Selling – SeekingAlpha
- Is This Profit Trend Your Friend? – The Motley Fool
- Time to Short Orthovita? – The Motley Fool
- RTI Biologics Inc. Q2 2010 Earnings Call Transcript – SeekingAlpha Transcripts
- RTI Biologics Inc. Q2 2010 Earnings Call Transcript – SeekingAlpha
- 4-Star Stocks Poised to Pop: RTI Biologics – The Motley Fool
- Two more bottoms for a perfect 10, and the first 2010 GBMB buy – Blog at The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool

RSS Headlines
Fool UK